Source: International Congress 2017 – Lung transplant outcomes



Rating:

Share or cite this content

Citations should be made in the following way:
F. Didier Neto (SAO PAULO/SP, Brazil). Chronic lung allograft disease: prevalence and FEV1 decline in a Brazilian lung transplant cohort.. 2469

Member's Comments

No comment yet.

Related content which might interest you: Rapid decline in lung disease other than COPD: when should lung transplantation be considered? Source: Annual Congress 2007 - Rapid decline in lung function and its consequences Year: 2007 Lung ultrasound to phenotype chronic lung allograft dysfunction in lung transplant recipients. A prospective observational study. Source: Virtual Congress 2021 – Thoracic ultrasound: future applications and current evidence Year: 2021 Lung volumes predict survival in patients with chronic lung allograft dysfunction Source: Eur Respir J , 49 (4)  1601315; DOI: 10.1183/13993003.01315-2016 Year: 2017 Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD) Source: International Congress 2018 – Rare lung diseases Year: 2018 Survival impact of lung transplantation for COPD Source: Eur Respir J 2010; 36: 74-80 Year: 2010 Breath VOC patterns of lung transplant recipients with and without chronic lung allograft dysfunction (CLAD) Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017 Prevalence of SDB in lung transplant recipients Source: Breathe 2010; 6: 274 Year: 2010 Acute respiratory failure: 7 years after monolateral lung transplant for COPD Source: International Congress 2018 – CC6 Interstitial lung diseases Year: 2018 Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the German COSYCONET cohort. Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases Year: 2019 Prevalence and outcomes of diabetes in lung transplant recipients: the portuguese experience Source: Virtual Congress 2020 – Clinical management of lung transplant recipients Year: 2020 Predictors for the rapid decline of FEV1 in chronic obstructive lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 255s Year: 2002 Risk factors for chronic lung allograft dysfunction (CLAD) in the SysCLAD cohort Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 Effect of the type of end-stage lung disease on postoperative evolution of lung transplantation patients Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012 Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Study of lung functions in patients of chronic liver disease. Source: International Congress 2017 – Miscellaneous clinical problems Year: 2017 Mortality risk and pulmonary function in adults with cystic fibrosis at time of wait listing for lung transplantation in the United States Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 Annual lung function changes in young patients with chronic lung disease Source: Eur Respir J 2002; 19: 886-891 Year: 2002 Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT® Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments Year: 2012 Chronic bronchitis among French adults: high prevalence and underdiagnosis Source: Eur Respir J 2002; 20: 806-812 Year: 2002